TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | ||||
TEST BANK FOR Advanced Practice Nursing
| | | | |
in the Care of Older Adults, 3rd Edition
| | | | | | | |
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
| | | | | | | |
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
Answers |at |the |end |of |the |Chapter
Chapter |1: |Changes |with |Aging
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
1. The major impact of the physiological changes that occur with aging is:
| | | | | | | | | | |
A. Reduced |physiological |reserve
B. Reduced |homeostatic |mechanisms
C. Impaired |immunological |response
D. All |of |the |above
2. The strongest evidence regarding normal physiological aging is available through:
| | | | | | | | |
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
A. Randomized |controlled |clinical |trials
B. Cross-sectional |studies
C. Longitudinal |studies
D. Case |control |studies
| 3. All |of|the |following |statements |are |true |about |laboratory
values |in |older |adultsexcept:
A. Reference|ranges |are |preferable
B. Abnormal |findings |are |often |due |to |physiological |aging
C. Normal |ranges |may |not |be |applicable |for |older |adults
D. Reference |values |are |not |necessarily |acceptable |values
| 4. Biochemical |individuality |is |best |described|as:
A. Each |individual’s |variation |is |often |much |greater | than |that |of |a |larger |group
B. The |unique |biochemical |profile |of |a |selected |population
C. The |truly |“normal” |individual—falling |within |average |range
D. Each |individual’s |variation |is |often |much |smaller |than |that |of |a |larger |group
| 5. Polypharmacy |is |best |described |as |taking:
A. More |than |nine |medications |per |day
B. More|than |five |medications |per |day
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
C. Even |a |single |medication |if |there |is |not |a |clear |indication |for |its |use
D. When |a |drug |is |given |to |treat |the |side |effect |of |another |drug
| 6. Pharmacokinetic |changes |with|aging |is |reflective |of:
A. What |the |drug |does |to |the |body
B. What |the |body |does |to |the |drug
C. The |effect |at |the |site |of |action |and |the |time |and |intensity |of |the |drug
D. The |side |effects |commonly |associated |with |the |drug
| 7. All |the |following |statements |are |false |about |drug |absorption |except:
A. Antacids |increase |the |bioavailability |of |digitalis
B. Gastric |acidity |decreases |with |age
C. Anticholinergics |increase |colonic |motility
D. Underlying |chronic |disease |has |little |impact |on |drug |absorption
| 8. All |of |the |following |statements |are |true |about |drug |distribution |in |the
elderly|except:
A. Drugs |distributed |in |water |have |lower |concentration
B. Drugs |distributed |in |fat |have |less |intense, | more |prolonged |effect
C. Drugs |highly |protein |bound |have |greater |potential |to |cause |an |adverse |drug |reaction
| | | | | | ||||
TEST BANK FOR Advanced Practice Nursing
| | | | |
in the Care of Older Adults, 3rd Edition
| | | | | | | |
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
| | | | | | | |
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
Answers |at |the |end |of |the |Chapter
Chapter |1: |Changes |with |Aging
Multiple |Choice
Identify |the |choice |that |best |completes |the |statement |or |answers |the |question.
1. The major impact of the physiological changes that occur with aging is:
| | | | | | | | | | |
A. Reduced |physiological |reserve
B. Reduced |homeostatic |mechanisms
C. Impaired |immunological |response
D. All |of |the |above
2. The strongest evidence regarding normal physiological aging is available through:
| | | | | | | | |
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
A. Randomized |controlled |clinical |trials
B. Cross-sectional |studies
C. Longitudinal |studies
D. Case |control |studies
| 3. All |of|the |following |statements |are |true |about |laboratory
values |in |older |adultsexcept:
A. Reference|ranges |are |preferable
B. Abnormal |findings |are |often |due |to |physiological |aging
C. Normal |ranges |may |not |be |applicable |for |older |adults
D. Reference |values |are |not |necessarily |acceptable |values
| 4. Biochemical |individuality |is |best |described|as:
A. Each |individual’s |variation |is |often |much |greater | than |that |of |a |larger |group
B. The |unique |biochemical |profile |of |a |selected |population
C. The |truly |“normal” |individual—falling |within |average |range
D. Each |individual’s |variation |is |often |much |smaller |than |that |of |a |larger |group
| 5. Polypharmacy |is |best |described |as |taking:
A. More |than |nine |medications |per |day
B. More|than |five |medications |per |day
, TO GET ALL CHAPTERS EMAIL ME AT>>>>>
| | | | | | |||
|
C. Even |a |single |medication |if |there |is |not |a |clear |indication |for |its |use
D. When |a |drug |is |given |to |treat |the |side |effect |of |another |drug
| 6. Pharmacokinetic |changes |with|aging |is |reflective |of:
A. What |the |drug |does |to |the |body
B. What |the |body |does |to |the |drug
C. The |effect |at |the |site |of |action |and |the |time |and |intensity |of |the |drug
D. The |side |effects |commonly |associated |with |the |drug
| 7. All |the |following |statements |are |false |about |drug |absorption |except:
A. Antacids |increase |the |bioavailability |of |digitalis
B. Gastric |acidity |decreases |with |age
C. Anticholinergics |increase |colonic |motility
D. Underlying |chronic |disease |has |little |impact |on |drug |absorption
| 8. All |of |the |following |statements |are |true |about |drug |distribution |in |the
elderly|except:
A. Drugs |distributed |in |water |have |lower |concentration
B. Drugs |distributed |in |fat |have |less |intense, | more |prolonged |effect
C. Drugs |highly |protein |bound |have |greater |potential |to |cause |an |adverse |drug |reaction
